Breaking News, Financial News

Roche

Group sales were up 9% in local currencies (lc).

Roche 1Q10

1Q10 Revenues: $11.5 billion (+15%)

Comments: Group sales were up 9% in local currencies (lc). Pharma sales were $9.1 billion, up 15% (6% lc), driven by the company’s oncology portfolio (+12% lc), with sales of Avastin up 18% to $1.8 billion. Diagnostics sales were up 16% (+7% lc) to $2.4 billion.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters